AXSM Axsome Therapeutics, Inc.

NASDAQ
$144.37

Axsome Therapeutics, Inc. (AXSM) is expected to report earnings on February 1, 2027, before the market open. The consensus earnings estimate is $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.3% since its last earnings release on November 2, 2026.

Axsome Therapeutics Beat Consensus Estimates
Monday, November 2, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 1
Monday · 7:00 AM ET
Earnings Whisper
-
vs $0.08
Rev est $278.35M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $138.06

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Axsome Therapeutics, Inc.

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.